Description
C-82 is an active metabolite of PRI-724 and is an inhibitor of beta-catenin. Endometriotic cyst stromal cells treated with C-82 in vitro showed inhibited cell growth, cell migration, and fibrosis.
Product Unit Size | Cost | Quantity | Stock |
---|
C-82 is an active metabolite of PRI-724 and is an inhibitor of beta-catenin. Endometriotic cyst stromal cells treated with C-82 in vitro showed inhibited cell growth, cell migration, and fibrosis.
Cas No. | 1422253-37-9 |
---|---|
Purity | ≥99% |
Formula | C33H34N6O4 |
Formula Wt. | 578.67 |
IUPAC Name | (6S,9S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide |
Synonym | C 82, C82 |
Appearance | White crystalline powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Hirakawa T, Nasu K, Miyabe S, et al. beta-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis. Sci Rep. 2019 Dec 27;9(1):20056. PMID: 31882904
Lafyatis R, Mantero J, Gordon J, et al. Inhibition of beta-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double-blind, placebo-controlled trial of C-82. J Invest Dermatol. 2017 Dec;137(12):2473-2483. PMID: 28807667
Calcium channel blocker.
DP1 antagonist.
Triterpene saponin found in species of Panax.
Antimicrobial peptide, generated during fibrin ...
Proteasome inhibitor, miR33b modulator.
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.
Peptide; GABA potentiator, NMDA negative allost...
Antioxidant.
Endogenous glycosaminoglycan that is produced b...
Amino acid precursor of dopamine.
Fermentation impurity
Micronuclei formation inducer, antimitotic, oxi...
Nucleoside (guanosine) analog; DNA chain termin...
MEK1/2 inhibitor.
FGFR inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
BHA derivative; potential Ca2+ ATPase inhibitor...
Opioid peptide; μOR agonist.
Imidzoline derivative; MDM2 inhibitor.
Isoquinoline alkaloid found in various plant so...